METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink tough tumors
Disease control CompletedThis study tested a new immunotherapy drug called ezabenlimab, given in combination with other cancer medicines, for adults with advanced cancers that had spread. The goal was to see if these combinations could shrink tumors and control the disease in patients who had already tri…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Cancer Drug's Long-Term safety checked for patients who keep benefiting
Disease control CompletedThis study aimed to learn more about the long-term safety of the cancer drug sacituzumab govitecan. It was for a small group of people (25 participants) whose metastatic cancer had already been controlled by this drug in a previous study. The main goal was to monitor for any side…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE4 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists unleash Triple-Threat immune attack on tough cancers
Disease control CompletedThis early-stage study tested a new combination of three immune-boosting drugs (IL-15, nivolumab, and ipilimumab) in adults with advanced cancers that had stopped responding to standard treatments. The main goal was to find the safest dose and understand the side effects of using…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Researchers map rare cancer gene to guide future treatments
Knowledge-focused CompletedThis study aimed to understand how often a specific genetic change called an NTRK fusion occurs in people with advanced solid tumors. Researchers analyzed tumor samples from over 3,800 patients who had already received cancer treatment. The goal was to gather information to help …
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Researchers hunt for clues to predict which advanced cancer patients are at highest risk after ER visit
Knowledge-focused CompletedThis study looked back at the medical records of 1,250 patients with advanced cancer who visited a hospital emergency department. The goal was to find common factors—like lab test results, overall health, and nutrition—that are linked to a higher risk of dying within 90 days of t…
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC